Home Compounds BPC-157 TB-500 CJC-1295 Ipamorelin GLP-1 GHK-Cu Epithalon NAD+ Comparisons BPC-157 vs TB-500 Sermorelin vs Ipamorelin Semaglutide vs Tirzepatide Guides GHK-Cu Guide GHRH Analogues Ipamorelin Guide Peptide Reconstitution Guide Peptide Storage Guide Research Guides Joint Pain Weight Loss Longevity Best Peptide Vendors All Vendor Comparisons Peptide Price Comparison Vendor Closures & Status How to Read a Peptide COA How to Vet a Peptide Vendor Why Purgo Labs Purgo Labs Review Purgo Labs Discount Code Where to Buy by Compound Legal Status Shop Purgo Labs

Retatrutide FDA Approval: Timeline, Phase 3 Status & Approval Date (2026)

Retatrutide is not FDA approved as of 2026. Phase 3 trials are ongoing. We cover the full FDA approval timeline, Phase 3 TRIUMPH program status, NDA submission estimate, and what approval would mean for the obesity drug landscape.